Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Healionics Corporation
Medtech Execs On The Move, April 2016
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Start-Up Execs On The Move, April 2016
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Execs On The Move, April 2016
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Healionics Spins Out Ophthalmic Device Company In Europe
Companies offering broadly applicable biomaterials platforms often have an identify problem and with that, a funding problem. Seattle-based Healionics Corp. is solving that problem by creating clinically focused spin-outs that just happen to be in Europe where they can capture non-dilutive funding from regional governments. The company’s first spin-out, iSTAR Medical SA, is working on ophthalmic devices, specifically a suprachoroidal drainage shunt for glaucoma. In September, iSTAR was awarded a €3.6 million ($4.7 million) grant from Belgium’s Région Wallonne government.
- Implantable Devices
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.